Genetically engineered T cell and tumour-infiltrating lymphocyte therapies
Haemato-oncology has made significant progress in recent years, particularly through the development of innovative immunotherapeutic approaches such as CAR T cell (chimeric antigen receptor T cell) and tumour-infiltrating lymphocyte therapies. Both methods use the patient’s own immune system to trea...
Saved in:
Main Authors: | Heinz Läubli, Andreas Holbro |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2025-07-01
|
Series: | Swiss Medical Weekly |
Online Access: | https://smw.ch/index.php/smw/article/view/4279 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumour-infiltrating lymphocyte therapy landscape: prospects and challenges
by: Arkadiusz Z Dudek, et al.
Published: (2025-08-01) -
Tumour budding, MELF-pattern and tumour-infiltrating lymphocytes as possible pathomorphological parameters of the course of endometrioid adenocarcinoma of the uterine corpus
by: D. A. Zinovkin, et al.
Published: (2024-07-01) -
ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer
by: In Hye Song, et al.
Published: (2017-10-01) -
Tumor-infiltrating lymphocyte therapy: therapeutic advances and prospects
by: Sarker Drishty Badhon, et al.
Published: (2025-01-01) -
CD8+ T-cell lymphocytes infiltration predict clinical outcomes in Wilms’ tumor
by: Keykhosro Mardanpour, et al.
Published: (2020-12-01)